Original Source(s)
Related Content
FDA Grants Accelerated Approval for OTOF Gene Therapy
A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.
April 23, 2026
-
3 min